Page last updated: 2024-08-21

azomycin and rhenium

azomycin has been researched along with rhenium in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cerecetto, H; Dematteis, S; Fernández, S; Giglio, J; Moreno, M; Pacheco, JP; Pietzsch, HJ; Rey, A1
Cerecetto, H; Fernández, S; Giglio, J; Rey, AM1
Chu, T; Mei, L; Wang, Y1

Other Studies

3 other study(ies) available for azomycin and rhenium

ArticleYear
Synthesis, in vitro and in vivo characterization of novel 99mTc-'4+1'-labeled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
    Nuclear medicine and biology, 2012, Volume: 39, Issue:5

    Topics: Animals; Biological Transport; Blood Proteins; Carcinoma, Lewis Lung; Cell Hypoxia; Cell Line, Tumor; Chemistry Techniques, Synthetic; Female; Humans; Hydrophobic and Hydrophilic Interactions; Isotope Labeling; Ligands; Mice; Nitroimidazoles; Organotechnetium Compounds; Rhenium

2012
Influence of ligand denticity on the properties of novel ⁹⁹mTc(I)-carbonyl complexes. Application to the development of radiopharmaceuticals for imaging hypoxic tissue.
    Bioorganic & medicinal chemistry, 2012, Jul-01, Volume: 20, Issue:13

    Topics: Animals; Cell Line, Tumor; Click Chemistry; Contrast Media; Coordination Complexes; Diagnostic Imaging; Humans; Ketones; Ligands; Metronidazole; Mice; Mice, Inbred C57BL; Neoplasms; Nitroimidazoles; Protein Binding; Proteins; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium; Tissue Distribution

2012
⁹⁹mTc/Re complexes bearing bisnitroimidazole or mononitroimidazole as potential bioreductive markers for tumor: synthesis, physicochemical characterization and biological evaluation.
    European journal of medicinal chemistry, 2012, Volume: 58

    Topics: Animals; Biomarkers, Tumor; Chemistry, Physical; Electrochemical Techniques; Mice; Mice, Inbred Strains; Molecular Structure; Nitroimidazoles; Organometallic Compounds; Oxidation-Reduction; Rats; Rhenium; Sarcoma, Experimental; Technetium; Tissue Distribution

2012